BioTelemetry (BEAT) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
BioTelemetry, Inc. Reports Third Quarter 2015 Financial Results
November 9, 2015 4:06 PM ESTMALVERN, Pa., Nov. 09, 2015 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2015.
Company Highlights
Achieved second consecutive quarter of profitability with $2.5 million GAAP net income  Experienced thirteenth consecutive quarter of year over year revenue growthGenerated positive adjusted EBITDA of $8.7 million, highest since 2008CMS issued final 2016 physician fee schedule with an increase of 8% for Mobile Cardiac... More